Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma.
Handel EE, McKeown J, Wei J, Kankaria RA, Burnette H, Johnson DB, Lawless A, Czapla J, Sullivan RJ, Albrecht LJ, Zimmer L, Mangana J, Dummer R, Kessels JI, Neyns B, Allayous C, Lebbe C, Boatwright C, Mehnert JM, Ottaviano M, Ascierto PA, Czarnecka AM, Rutkowski P, Lo SN, Long GV, Menzies AM, Carlino MS.
Handel EE, et al. Among authors: sullivan rj.
Eur J Cancer. 2024 Dec 9;215:115171. doi: 10.1016/j.ejca.2024.115171. Online ahead of print.
Eur J Cancer. 2024.
PMID: 39667250